News archive

The symposium is organized jointly by the Medicinal Chemistry Section of the Swedish Pharmaceutical Society and ENABLE, one of the projects in the Innovative Medicines Initiative ND4BB, to showcase the future and opportunities for antibiotic drug discovery in a stimulating environment. It is also designed to provide plenty of opportunities to meet other delegates, renew […]

The JPIAMR, in partnership with 8 European countries (Belgium, France, Germany, Netherlands, Norway, Spain, Sweden and the UK), and Canada, is launching a fourth joint call for working group proposals.  The call sets out to assemble motivated groups of leading experts and establish Working Groups in order to enhance resource alignment and maximise existing and […]

IMI2 Prelaunch Flyer The Innovative Medicines Initiative (IMI) will soon launch its 9th Call for proposals under IMI 2. The Call will include the topic: Addressing the clinical burden of Clostridium difficile infection (CDI): evaluation of the burden, current practices and set up of a European research platform (part of the IMI New Drugs for […]

The Conference will review what needs to be done to achieve a more prudent and appropriate use of antibiotics in the European Union (EU), with an emphasis on human use. It will bring together experts and policy makers on antimicrobial resistance. Read more

The development of new antibiotics is a major aspect strongly associated to AMR. In a two days symposium international experts communicate state-of-the-art science from the definition of the problem. Read more    

The Bill and Melinda Gates foundation has launched a call for ‘Novel Approaches to Characterizing and Tracking the Global Burden of Antimicrobial Resistance’. The goal is to identify approaches that provide more robust and reliable evidence regarding the global scale, impact, and/or transmission dynamics of AMR, specifically as applicable to low- and middle-income settings. The call also […]

The European Parliament could play a crucial role in shaping a European prudent use of antibiotics policy and JPIAMR can provide evidence and data to support such a policy. JPIAMR should also provide best practice guidelines. This was the main message from a meeting JPIAMR organised on 16 February 2016 with European Parliamentarians to discuss […]

This article was published in the Parliament Magazine February issue 2016. Antimicrobial resistance (AMR) has led to a global increase in morbidity and mortality due to resistant bacterial infections. Bacteria develop resistance naturally. It is hence not enough to only develop new antibiotics as the bacteria, through the process of selective pressure, will always find […]

The Dutch presidency has told Europe’s ministers of health and agriculture they must work together if antimicrobial resistance is to be tackled reports Research Professional. Europe’s governments must set aside worries about subsidiarity and make tackling antimicrobial resistance a common priority, Edith Schippers, the Dutch minister of health, welfare and sport, told delegates at a […]

On 20-21 January 2016, the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), the US National Institute of Health (NIH) and the US National Institute of Allergy and Infectious Diseases (NIAID), organised a meeting which brought together scientists in the field of antibacterial resistance. The aim was to increase the trans-Atlantic dialogue and encourage scientific collaboration […]